Adaptimmune Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADAP and other ETFs, options, and stocks.

About ADAP

Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8.

CEO

Adrian Rawcliffe

CEOAdrian Rawcliffe

Employees

506

Employees506

Headquarters

Abingdon, Oxfordshire

HeadquartersAbingdon, Oxfordshire

Founded

2014

Founded2014

Employees

506

Employees506

ADAP Key Statistics

Market cap

62.63M

Market cap62.63M

Price-Earnings ratio

-0.89

Price-Earnings ratio-0.89

Dividend yield

—

Dividend yield—

Average volume

684.49K

Average volume684.49K

High today

$0.2528

High today$0.2528

Low today

$0.23

Low today$0.23

Open price

$0.2378

Open price$0.2378

Volume

937.87K

Volume937.87K

52 Week high

$1.48

52 Week high$1.48

52 Week low

$0.1951

52 Week low$0.1951

Analyst ratings

50%

of 8 ratings

Buy

37.5%

Hold

50%

Sell

12.5%